Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome
Hee Sun Baek
Child Kidney Dis. 2022;26(1):25-30.   Published online 2022 Jun 16     DOI: https://doi.org/10.3339/ckd.22.020
Citations to this article as recorded by Crossref logo
Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low-density Lipoprotein Apheresis: A Case Series
Hisato Shima, Yusuke Higashiguchi, Toshio Doi, Megumi Harada, Takuya Okamoto, Tomoko Inoue, Manabu Tashiro, Kazuyoshi Okada, Jun Minakuchi
Internal Medicine.2023;[Epub]     CrossRef
Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome
Seoyun Jang, Yo Han Ahn, Jung Min Ko, Jae Sung Ko, Sojung Lim, Hee Gyung Kang
Frontiers in Pediatrics.2022;[Epub]     CrossRef